此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

氯己定与桑葚漱口水在牙周治疗后的疗效

2026年11月2日 更新者:Burak Koçak、Inonu University

氯己定与黑桑漱口水治疗牙周病疗效比较

This study aims to evaluate and compare the clinical, biochemical, and microbiological effects of chlorhexidine and Morus nigra (blackberry) mouthwashes used as an adjunct to non-surgical periodontal treatment (scaling and root planing - SRP) in patients with periodontal diseases. The participants will be divided into three groups: a control group receiving only SRP, a group receiving SRP combined with chlorhexidine mouthwash, and a group receiving SRP combined with Morus nigra mouthwash. Clinical periodontal parameters, gingival crevicular fluid levels of inflammatory markers (including TNF-a, IL-1b, and IL-10), and subgingival plaque microbiological profiles (such as red complex bacteria and Fusobacterium) will be evaluated at baseline, 1 month, and 3 months after the treatment.

研究概览

研究类型

介入性

注册 (实际的)

48

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Malatya
      • Battalgazi、Malatya、土耳其(türkiye)、44300
        • Inonu University Faculty of Dentistry

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients diagnosed with periodontitis.
  • Systemically healthy individuals.
  • Patients aged between 18 and 65 years.
  • Presence of at least 20 natural teeth.
  • Volunteering to participate in the study and signing the informed consent form.

Exclusion Criteria:

  • Presence of any systemic disease that may affect periodontal health or systemic inflammatory response (e.g., Diabetes Mellitus, immunological disorders).
  • Current smokers or use of any tobacco products.
  • Pregnancy or lactation.
  • Use of systemic antibiotics, anti-inflammatory drugs, or immunosuppressive medications within the last 6 months.
  • Having received any non-surgical or surgical periodontal treatment within the last 6 months.
  • Known allergy or sensitivity to chlorhexidine or Morus nigra (blackberry) extracts.
  • Patients using orthodontic appliances.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Control Group

Non-surgical periodontal treatment consisting of full-mouth scaling and root planing (SRP) using ultrasonic and hand instruments.

All patients in the study underwent non-surgical periodontal therapy consisting of full-mouth scaling and root planing (SRP) using both ultrasonic devices and hand instruments.

实验性的:Chlorhexidine Group

As an adjunct to scaling and root planing, patients will rinse with 15 ml of 0.12% chlorhexidine gluconate mouthwash twice a day (morning and evening) for 1 minute. The duration of the intervention is 14 days.

All patients in the study underwent non-surgical periodontal therapy consisting of full-mouth scaling and root planing (SRP) using both ultrasonic devices and hand instruments.

As an adjunct to SRP, patients were instructed to rinse with 15 ml of 0.12% chlorhexidine gluconate mouthwash twice daily (morning and evening) for 1 minute. The treatment duration was 14 days.

实验性的:Morus Nigra Group

As an adjunct to scaling and root planing, patients will rinse with 15 ml of a standardized mouthwash containing 5% Morus nigra extract twice a day (morning and evening) for 1 minute. The duration of the intervention is 14 days.

All patients in the study underwent non-surgical periodontal therapy consisting of full-mouth scaling and root planing (SRP) using both ultrasonic devices and hand instruments.

As an adjunct to SRP, patients were instructed to rinse with 15 ml of a standardized mouthwash containing 5% Morus nigra extract twice daily (morning and evening) for 1 minute. The treatment duration was 14 days.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Gingival Index (GI)
大体时间:Baseline (Day 0), 1 month, and 3 months after periodontal treatment.

Evaluation of gingival inflammation using a scale of 0 to 3.

Baseline (Day 0), 1 month, and 3 months after periodontal treatment.
Plaque Index (PI)
大体时间:Baseline (Day 0), 1 month, and 3 months after periodontal treatment.

Evaluation of plaque accumulation using a scale of 0 to 3.

Baseline (Day 0), 1 month, and 3 months after periodontal treatment.
Probing Depth (PD)
大体时间:Baseline (Day 0), 1 month, and 3 months after periodontal treatment.

Measurement of the distance from the gingival margin to the bottom of the periodontal pocket.

Baseline (Day 0), 1 month, and 3 months after periodontal treatment.
Clinical Attachment Level (CAL)
大体时间:Baseline (Day 0), 1 month, and 3 months after periodontal treatment.

Measurement of the distance from the cementoenamel junction to the bottom of the periodontal pocket.

Baseline (Day 0), 1 month, and 3 months after periodontal treatment.
Bleeding on Probing (BOP)
大体时间:Baseline (Day 0), 1 month, and 3 months after periodontal treatment.

Evaluation of the presence or absence of bleeding within 30 seconds after probing. The result is recorded as a percentage of sites that bleed.

Baseline (Day 0), 1 month, and 3 months after periodontal treatment.

次要结果测量

结果测量
措施说明
大体时间
Change in Gingival Crevicular Fluid (GCF) Inflammatory Markers
大体时间:At baseline, 1 month, and 3 months after treatment

Analysis of TNF-a, IL-1b, and IL-10 levels in the gingival crevicular fluid using ELISA (or specific biochemical assay) to evaluate the local inflammatory response

At baseline, 1 month, and 3 months after treatment
Change in Subgingival Plaque Microbiological Profile
大体时间:At baseline, 1 month, and 3 months after treatment

Evaluation of subgingival plaque samples to determine the levels of red complex bacteria and Fusobacterium nucleatum using PCR (Polymerase Chain Reaction) analysis

At baseline, 1 month, and 3 months after treatment

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年5月8日

初级完成 (实际的)

2026年6月1日

研究完成 (实际的)

2026年7月1日

研究注册日期

首次提交

2026年3月23日

首先提交符合 QC 标准的

2026年4月14日

首次发布 (实际的)

2026年4月20日

研究记录更新

最后更新发布 (实际的)

2026年11月4日

上次提交的符合 QC 标准的更新

2026年11月2日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

De-identified individual participant data that underlie the results reported in the published article will be shared

IPD 共享时间框架

Data will be available beginning 6 months and ending 36 months following article publication.

IPD 共享访问标准

Data will be shared with researchers who provide a methodologically sound proposal. Requests for data sharing should be directed to the principal investigator via email

IPD 共享支持信息类型

  • 研究方案
  • 树液

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅